As the world races to find a vaccine for COVID-19, our colleague Dr Cem Gun, an Emergency Medicine Physician at Acıbadem University Atakent Hospital, has bravely volunteered for the country’s first clinical trial. On 9 October, he was administered the first dose of a COVID-19 vaccine developed in China and approved for trial by the Health Institutes of Turkey, at a high-key milestone event.
On why he volunteered for this trial, Dr Cem Gun said, “As a healthcare worker, I fall into the high-risk group for COVID-19 infection. I decided to be vaccinated not only to protect myself but also my patients and loved ones. I made this decision with peace of mind as it is a controlled trial; it is currently in Phase 3, making it a tested and safe vaccine.”
The vaccine will be administered in two doses, and volunteers will be monitored on its effectiveness over a year.
The World Bank has approved US$12 billion in financing to help developing countries buy and distribute COVID-19 vaccines, tests and treatments, aiming to support the vaccination of up to 1 billion people.
Related Stories
Premier Integrated Rehab Marks 25 Years with a Renewed Commitment to Rehab Care
Premier Integrated Rehab has embarked on a new chapter in its journey, unveiling a refreshed brand identity in celebration of its 25th anniversary.
Gleneagles Hospital Hong Kong Forms Strategic Partnerships to Advance AI-Driven Healthcare & Diagnostic Innovation
Gleneagles Hospital Hong Kong has entered into two significant collaborations aimed at enhancing patient care through advanced technology and diagnostics.
Championing Cross-Country Care at the Asia Summit on Global Health
Gleneagles is proud to mark its fifth consecutive year as the Future Private Health Partner at the Asia Summit on Global Health (ASGH).
-(11).png?sfvrsn=660b02e5_1)
Fortis Hospital Vasant Kunj Launches Dedicated Obesity Clinic to Tackle India’s Growing Health Challenge
Fortis Hospital Vasant Kunj has taken a significant step forward in addressing India’s obesity epidemic by offering comprehensive, multidisciplinary care.
Mind Matters: Premier Integrated Labs Champions Early Alzheimer’s Detection
Premier Integrated Labs is leading efforts to advance early diagnosis and understanding of Alzheimer’s disease in Malaysia – a critical step in improving outcomes for patients and families affected by the condition.
Gleneagles JPMC Shines a Light on Unsung Heroes During Perfusion Week
At Gleneagles JPMC, where advancing cardiac health is at the heart of what we do, Perfusion Week, celebrated from 1 to 7 May, provided a meaningful opportunity to honour a group of professionals whose vital contributions often happen out of the spotlight – our perfusionists.
